Cargando…
肺鳞癌靶向治疗研究现状
With the research of driver mutations, targeted therapy for lung cancer has made a great progress. Compared with lung adenocarcinoma, treatment of squamous cell lung cancer (SCC) has been far behind. While targeted therapies have improved outcomes for patients with lung adenocarcinoma, such as EGFR-...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015175/ https://www.ncbi.nlm.nih.gov/pubmed/24113011 http://dx.doi.org/10.3779/j.issn.1009-3419.2013.10.11 |